2025 Event

Fierce Biotech Week

Date: October 7th-9th
Location: Boston, MA

Booth #319
Fierce Biotech Week brings together the brightest minds in drug development, clinical research, business development & licensing, TMF, and communications to advance innovation and shape biotech’s future. Get ready to spark new partnerships, accelerate breakthroughs, and lead in this dynamic and rapidly evolving industry. Meet with the Cencora TMF Solutions team.  
 

Join us for a speaker session

Incorporating AI to Improve the Management of the Trial Master File

Date: Day 1, Tue, Oct 7
Time: 9:30 AM - 10:00 AM

Amidst our changing and fast-moving industry landscape, artificial intelligence has made a significant impact on the accuracy and efficiency of TMF Management. AI can assist with not only document classification but also document quality, completeness oversight, and even regulatory compliance. But it's important to understand that while AI is not high risk, it is also not perfect! Join us as we talk through different opportunities to leverage AI while also discussing considerations to consider during implementation.
Jake headshot

Our speaker

Jake McDonald

Meet Jake McDonald, a dynamic Solutions Consultant at Cencora with over a decade of experience in the world of Trial Master Files (TMF). Jake's journey began in processing, where he quickly caught the clinical bug and knew he wanted more. His passion for TMF led him to specialize in implementation and delivery, where he dove headfirst into the intricacies of technical and business processes, mastering the art of TMF filing structures. Now, in the realm of business development, Jake thrives on advocating for end users. He loves solving complex challenges and crafting real-world solutions that make a difference. Whether it’s untangling a TMF conundrum or streamlining processes, Jake is all about transforming obstacles into opportunities.

Join our team of experts at booth #319

Seth Pearl headshot
Seth Pearl
Director Business Development
Nadine Ralph headshot
Nadine Ralph, MBA
Managing Director, US & PR
headshot
Jake McDonald
TMF Solution Consultant

With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise

3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented

Helping breakthroughs break through
 

At Cencora, we’re leading the way to a place where your life-changing therapies can soar to impossible heights. Together, let’s create healthier futures for more patients around the globe.
professional man using laptop

Implementing risk-based quality review for an inspection-ready TMF

Join Jake McDonald, our TMF Solution Consultant, to discover how risk-based TMF quality checks (QC) and quality reviews (QR) can enhance TMF quality while saving time and resources. Learn the key differences between QC and QR, the various types of quality reviews, and how to apply them effectively.

Additionally, identify common risks found in clinical documentation processes, even among experienced TMF teams, and present proven tools and methodologies that provide actionable insights into the risk profile of your Trial Master File.

TMF Solutions

Cencora's comprehensive TMF solution suite helps ensure your Trial Master File remains inspection-ready while enabling your internal teams to focus on advancing clinical trials.  

Meet with us at Fierce Biotech

Interested in learning more? We're here to answer questions and to support your TMF Solution needs. Schedule time to meet with our team at the event.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.